Intercept Pharmaceuticals | Capitale Sociale E Riserve

Equity Capital And Reserves Cambiamento Data
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amarin USD 553.15M 15.98M 2023-09
Amgen USD 6.23B 1.42B 2023-12
Arrowhead Research USD 160.41M 110.94M 2023-12
AstraZeneca USD 37.2B 195M 2023-09
Biogen USD 14.8B 315.6M 2023-12
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
GlaxoSmithKline GBP 13.13B 442M 2023-09
Incyte USD 5.19B 258.39M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Moderna USD 13.85B 399M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
PTC Therapeutics USD -818555000 147.74M 2023-12
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Intercept Pharmaceuticals Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.